Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-10-011887

Options or other derivatives

  • Chief Executive Officer acquired 4,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Carpenter George C IV Chief Executive Officer 2010-03-03 Grant or award · Stock Option (Right to Buy) +4,000,000 4,000,000 D
Loading xslF345X03/v176507_ex.xml…